| [1] |
Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium[J]. Oncologist, 2011, 16(11):1589-1599.
|
| [2] |
Faia LJ, Chan CC. Primary Intraocular Lymphoma[J]. Arch Pathol Lab Med, 2009, 133(8):1228-1232.
|
| [3] |
刘忆南，魏文斌. 眼内及眼附属器淋巴瘤的组织病理学表现[J]. 国际眼科纵览，2015,39(6):418-422.
|
| [4] |
周旻，江睿，张艳琼，等. 原发性眼内淋巴瘤13例[J]. 中华眼底病杂志，2012,28(3):245-248.
|
| [5] |
Chan CC, Fisson S, Bodaghi B. The future of primary intraocular lymphoma (retinal lymphoma)[J]. Ocul Immunol Inflamm, 2009, 17(6):375-379.
|
| [6] |
Cao X, Shen D, Callanan DG, et al. Diagnosis of systemic metastatic retinal lymphoma[J]. Acta Ophthalmologica, 2011, 89(2):149-154.
|
| [7] |
Hong JT, Chae JB, Lee JY, et al. Ocular involvement in patients with primary CNS lymphoma[J]. Journal of Neuro－Oncology, 2011, 102(1):139-145.
|
| [8] |
Faia LJ, Chan CC. Primary intraocular lymphoma[J]. Annals of Ophthalmology, 2001, 33(3):233-236.
|
| [9] |
Hwang CS, Yeh S, Bergstrom CS. Diagnostic vitrectomy for primary intraocular lymphoma: when, why, how？[J]. Int Ophthalmol Clin, 2014, 54(2):155-171.
|
| [10] |
李孟达，叶俊杰. 原发性眼内淋巴瘤的研究进展[J]. 中华眼科杂志，2015,51(10):795-800.
|
| [11] |
Coupland SE, Chan CC, Smith J. Pathophysiology of retinal lymphoma[J]. Ocul Immunol Inflamm, 2009, 17(4):227-237.
|
| [12] |
Hochberg FH, Miller DC. Primary central nervous system lymphoma[J]. J Neurosurg, 1988, 68(6):835-853.
|
| [13] |
王敏，张美芬. 原发性眼内淋巴瘤[J]. 中华眼底病杂志，2015,31(2):208-211.
|
| [14] |
Mochizuki M, Singh AD. Epidemiology and clinical features of intraocular lymphoma[J]. Ocul Immunol Inflamm, 2009, 17(2):69-72.
|
| [15] |
Davis JL. Intraocular lymphoma: a clinical perspective[J]. Eye(Lond), 2013, 27(2):153-162.
|
| [16] |
Zamora DO, Riviere M, Choi D, et al. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin[J]. Mol Vis, 2007, 13(233):2058-2065.
|
| [17] |
Sauer TC, Meyers SM, Shen DF, et al. Primary intraocular (retinal) lymphoma after ocular toxoplasmosis[J]. Retin Cases Brief Rep, 2010, 4(2):160-163.
|
| [18] |
Malumbres R, Davis J, Ruiz P, et al. Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B－cell lymphomas[J]. Br J Haematol, 2007, 138(6):749-755.
|
| [19] |
Kim YK, Kim HJ, Woo KI, et al. Intraocular lymphoma after cardiac transplantation: magnetic resonance imaging findings[J]. Korean J Radiol, 1900, 14(1):122-125.
|
| [20] |
Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan[J]. Jpn J Ophthalmol, 2007, 51(1):41-44.
|
| [21] |
Vollmer L. The diagnosis and management of ocular lymphoma[J]. Optom Vis Sci, 2013, 90(2):56-62.
|
| [22] |
Casady M, Faia L, Nazemzadeh M, et a1. Fundus autofluorescence patterns in primary intraocular lymphoma[J]. Retina, 2014, 34(2):366-372.
|
| [23] |
Velez G, Chan CC, Csaky KG. Fluorescein angiographic findings in primary intraocular lymphoma[J]. Retina, 2002, 22(1):37-43.
|
| [24] |
Egawa M, Mitamura Y, Hayashi Y, et al. Spectral－domain optical coherence tomographic and fundus autofluorescence findings in eyes with primary intraocular lymphoma[J]. Clinical Ophthalmology, 2014, 8(default):335-341.
|
| [25] |
Egawa M, Mitamura Y, Hayashi Y, et al. Changes of fundus autofluorescence and spectral－domain optical coherence tomographic findings after treatment of primary intraocular lymphoma[J]. Journal of Ophthalmic Inflammation and Infection, 2014, 4(1):7.
|
| [26] |
Jang HS, Sepah YJ, Sophie R, et al. Longitudinal spectral domain optical coherence tomography changes in eyes with intraocular lymphoma[J]. J Ophthalmic Inflamm Infect, 2013, 3(1):59.
|
| [27] |
Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome[J]. Graefe′s Archive for Clinical and Experimental Ophthalmology, 2003, 241(10):860-870.
|
| [28] |
Kanavi MR, Soheilian M, Hosseini SB, et al. 25－gauge transconjunctival diagnostic vitrectomy in suspected cases of intraocular lymphoma: a case series and review of the literature[J]. Int J Ophthalmol, 2014, 7(3):577-581.
|
| [29] |
Yeh S, Weichel ED, Faia LJ, et al. 25－gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma[J]. Br J Ophthalmol, 2010, 94(5):633-638.
|
| [30] |
Cassoux N, Giron A, Bodaghi B, et al. IL－10 Measurement in Aqueous Humor for Screening Patients with Suspicion of Primary Intraocular Lymphoma[J]. Invest Ophthalmol Vis Sci, 2007, 48(7):3253-2359.
|
| [31] |
Whitcup SM, Starkvancs V, Wittes RE, et al. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma[J]. Arch Ophthalmol, 1997, 115(9):1157-1160.
|
| [32] |
Sugita S, Takase H, Sugamoto Y, et al. Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid[J]. Japanese Journal of Ophthalmology, 2009, 53(3):209-214.
|
| [33] |
Kimura K, Usui Y, Goto H. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma[J]. Japanese Journal of Ophthalmology, 2012, 56(4):383-389.
|
| [34] |
Smith JR, Rosenbaum JT, Wilson DJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement[J]. Ophthalmology, 2002, 109(9):1709-1716.
|
| [35] |
DeAngelis LM. Primary central nervous system lymphomas[J]. Curr Treat Options in Oncol, 2001, 2(4):309-318.
|
| [36] |
Valluri S, Moorthy RS, Khan A, et al. Combination treatment of intraocular lymphoma[J]. Retina, 1995, 15(2):125.
|
| [37] |
Mason JO, Fischer DH. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma[J]. Ophthalmology, 2003, 110(6):1241-1244.
|
| [38] |
Soussain C, Merle－Béral H, Reux I, et al. A single－center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high－dose chemotherapy and autologous bone marrow transplantation in 5 cases[J]. Leukemia & Lymphoma, 1996, 23(3-4):339.
|
| [39] |
Helbig H, Cerny T, de Smet MD. Intravitreal chemotherapy for intraocular lymphoma[J]. Der Ophthalmologe, 2003, 100(2):145-149.
|
| [40] |
Jahnke K, Bechrakis NE, Coupland SE, et al. Treatment of primary intraocular lymphoma with oral trofosfamide: report of two cases and review of the literature[J]. Graefe′s Archive for Clinical and Experimental Ophthalmology, 2004, 242(9):771.
|
| [41] |
Feugier P, Virion JM, Tilly H, et al. Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large－B－cell lymphoma: influence of rituximab[J]. Annals of Oncology, 2004, 15(1):129.
|
| [42] |
Ferreri AJ, Blay JY, Reni M, et al. Relevance of intraocular involvement in the management of primary central nervous system lymphomas[J]. Annals of Oncology, 2002, 13(4):531-538.
|
| [43] |
Buggage RR, Chan CC, Nussenblatt RB. Ocular manifestations of central nervous system lymphoma[J]. Current Opinion in Oncology, 2001, 13(13):137-142.
|